These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19276766)

  • 1. Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute.
    Schurr MJ; Foster KN; Centanni JM; Comer AR; Wicks A; Gibson AL; Thomas-Virnig CL; Schlosser SJ; Faucher LD; Lokuta MA; Allen-Hoffmann BL
    J Trauma; 2009 Mar; 66(3):866-73; discussion 873-4. PubMed ID: 19276766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.
    Centanni JM; Straseski JA; Wicks A; Hank JA; Rasmussen CA; Lokuta MA; Schurr MJ; Foster KN; Faucher LD; Caruso DM; Comer AR; Allen-Hoffmann BL
    Ann Surg; 2011 Apr; 253(4):672-83. PubMed ID: 21475006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Evaluation of NIKS-Based Bioengineered Skin Substitute Tissue in Complex Skin Defects: Phase I/IIa Clinical Trial Results.
    Schurr MJ; Foster KN; Lokuta MA; Rasmussen CA; Thomas-Virnig CL; Faucher LD; Caruso DM; Allen-Hoffmann BL
    Adv Wound Care (New Rochelle); 2012 Apr; 1(2):95-103. PubMed ID: 24527287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label, prospective, randomized, controlled, multicenter, phase 1b study of StrataGraft skin tissue versus autografting in patients with deep partial-thickness thermal burns.
    Holmes JH; Schurr MJ; King BT; Foster K; Faucher LD; Lokuta MA; Comer AR; Rooney PJ; Barbeau KF; Mohoney ST; Gibson ALF; Lynn Allen-Hoffmann B
    Burns; 2019 Dec; 45(8):1749-1758. PubMed ID: 31416637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase 3, open-label, controlled, randomized, multicenter trial evaluating the efficacy and safety of StrataGraft® construct in patients with deep partial-thickness thermal burns.
    Gibson ALF; Holmes JH; Shupp JW; Smith D; Joe V; Carson J; Litt J; Kahn S; Short T; Cancio L; Rizzo J; Carter JE; Foster K; Lokuta MA; Comer AR; Smiell JM; Allen-Hoffmann BL
    Burns; 2021 Aug; 47(5):1024-1037. PubMed ID: 34099322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 3b, open-label, single-arm, multicenter, expanded-access study of the safety and clinical outcomes of StrataGraft® treatment in adults with deep partial-thickness thermal burns.
    Holmes Iv JH; Gibson ALF; Short T; Joe VC; Litt J; Carson J; Carter JE; Wibbenmeyer L; Hahn H; Smiell JM; Rutan R; Wu R; Shupp JW
    Burns; 2024 Nov; 50(8):2013-2022. PubMed ID: 39043513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pooled safety analysis of STRATA2011 and STRATA2016 clinical trials evaluating the use of StrataGraft® in patients with deep partial-thickness thermal burns.
    Holmes Iv JH; Cancio LC; Carter JE; Faucher LD; Foster K; Hahn HD; King BT; Rutan R; Smiell JM; Wu R; Gibson ALF
    Burns; 2022 Dec; 48(8):1816-1824. PubMed ID: 35941023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds.
    Purdue GF; Hunt JL; Still JM; Law EJ; Herndon DN; Goldfarb IW; Schiller WR; Hansbrough JF; Hickerson WL; Himel HN; Kealey GP; Twomey J; Missavage AE; Solem LD; Davis M; Totoritis M; Gentzkow GD
    J Burn Care Rehabil; 1997; 18(1 Pt 1):52-7. PubMed ID: 9063788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioartificial dermal substitute: a preliminary report on its use for the management of complex combat-related soft tissue wounds.
    Helgeson MD; Potter BK; Evans KN; Shawen SB
    J Orthop Trauma; 2007 Jul; 21(6):394-9. PubMed ID: 17620998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-Transitional Covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds.
    Hansbrough JF; Mozingo DW; Kealey GP; Davis M; Gidner A; Gentzkow GD
    J Burn Care Rehabil; 1997; 18(1 Pt 1):43-51. PubMed ID: 9063787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor regulates NIKS keratinocyte proliferation through Notch signaling.
    Roy M; King TW
    J Surg Res; 2013 Nov; 185(1):6-11. PubMed ID: 23899513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closure of the excised burn wound: temporary skin substitutes.
    Saffle JR
    Clin Plast Surg; 2009 Oct; 36(4):627-41. PubMed ID: 19793557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric composite skin substitutes for delivery of autologous keratinocytes to promote tissue regeneration.
    Rasmussen CA; Gibson AL; Schlosser SJ; Schurr MJ; Allen-Hoffmann BL
    Ann Surg; 2010 Feb; 251(2):368-76. PubMed ID: 20010085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous full-thickness skin substitute for healing chronic wounds.
    Gibbs S; van den Hoogenband HM; Kirtschig G; Richters CD; Spiekstra SW; Breetveld M; Scheper RJ; de Boer EM
    Br J Dermatol; 2006 Aug; 155(2):267-74. PubMed ID: 16882162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-center, open-labeled, randomized, 6-month, parallel-group study to assess the safety and efficacy of allogeneic cultured keratinocyte sheet transplantation for deep second-degree burn wounds: rationale and design of phase I/II clinical trial.
    Farzanbakhsh S; Shahrbaf MA; Madani H; Dahmardei M; Sadri B; Vosough M
    Trials; 2024 Apr; 25(1):226. PubMed ID: 38556879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin substitute-assisted repair shows reduced dermal fibrosis in acute human wounds validated simultaneously by histology and optical coherence tomography.
    Greaves NS; Iqbal SA; Hodgkinson T; Morris J; Benatar B; Alonso-Rasgado T; Baguneid M; Bayat A
    Wound Repair Regen; 2015; 23(4):483-94. PubMed ID: 26053202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cultured Autologous Dermo-epidermal Skin Substitute for Full-Thickness Skin Defects: A Phase I, Open, Prospective Clinical Trial in Children.
    Meuli M; Hartmann-Fritsch F; Hüging M; Marino D; Saglini M; Hynes S; Neuhaus K; Manuel E; Middelkoop E; Reichmann E; Schiestl C
    Plast Reconstr Surg; 2019 Jul; 144(1):188-198. PubMed ID: 31246829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn wounds.
    Purdue GF; Hunt JL; Gillespie RW; Hansbrough JF; Dominic WJ; Robson MC; Smith DJ; MacMillan BG; Waymac JP; Herndon DN
    J Trauma; 1987 Feb; 27(2):155-7. PubMed ID: 3546711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of Biobrane™ and cadaveric allograft for temporizing the acute burn wound: Cost and procedural time.
    Austin RE; Merchant N; Shahrokhi S; Jeschke MG
    Burns; 2015 Jun; 41(4):749-53. PubMed ID: 25458501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repair of refractory wounds through grafting of artificial dermis and autologous epidermis aided by vacuum-assisted closure.
    Zhang C; Liu D; Liang Z; Liu F; Lin H; Guo Z
    Aesthetic Plast Surg; 2014 Aug; 38(4):727-32. PubMed ID: 24902915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.